ArticleExpert review of precision medicine and drug development

Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation.

Deborah M Cholon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.